Keyphrases
Tumor Microenvironment
100%
Photothermal Therapy
100%
DLL4
100%
Nanoparticle Uptake
100%
Tumor
38%
Theranostic Nanoparticles
30%
Enhanced Retention
23%
Enhanced Permeation
23%
Retention Effect
23%
Permeation Effect
23%
Therapy Response
15%
Chemotherapy Sensitivity
15%
Host Strains
15%
Triple-negative Breast Cancer
7%
Magnetic Resonance Imaging
7%
Nanoparticles
7%
Molecular Targets
7%
Tumor Targeting
7%
Patient-specific Therapy
7%
Breast Tumor
7%
Human Breast Cancer
7%
Congenic Strain
7%
Rat Strains
7%
Vasculature
7%
Host Specificity
7%
Antibody Conjugates
7%
Geographic Distribution
7%
Resistant Strains
7%
Image-guided
7%
Breast Cancer Xenograft
7%
Therapy Resistance
7%
Tumor Xenograft
7%
Close Proximity
7%
Improved Efficacy
7%
Salt Sensitivity
7%
Chromosome 3
7%
Triple Negative
7%
Au Nanorods (AuNRs)
7%
Tumor Endothelium
7%
Nanoparticle Distribution
7%
Brown Norway Rat
7%
Consomic Rats
7%
X-ray Contrast
7%
Response Difference
7%
Multimodal Theranostics
7%
Vascular Heterogeneity
7%
Optical Contrast
7%
Personalized Nanomedicine
7%
Low Strain
7%
Plasmonic Photothermal Therapy
7%
Medicine and Dentistry
Tumor Microenvironment
100%
Photothermal Therapy
100%
Nanoparticle
100%
Neoplasm
87%
Allele
37%
Treatment Response
25%
Tumor Xenograft
25%
Magnetic Resonance Imaging
12%
Vascularity
12%
Breast Cancer
12%
Geographic Distribution
12%
Triple Negative Breast Cancer
12%
Therapy Resistance
12%
Chromosome 3
12%
Nanomedicine
12%
Notch
12%
Gold Nanorod
12%
Table Salt
12%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Nanoparticle
100%
Tumor Microenvironment
100%
Photothermal Therapy
100%
Triple Negative Breast Cancer
12%
Breast Cancer
12%
Therapy Resistance
12%
Nanomedicine
12%
Brown Norway Rat
12%
Geographic Distribution
12%
Rat Strain
12%
Table Salt
12%
Gold Nanorod
12%
Biochemistry, Genetics and Molecular Biology
DLL4
100%
Allele
23%
Vascularization
7%
X Ray
7%
Congenic Strain
7%
Notch
7%
Chromosome 3
7%
Geographic Distribution
7%
Rat Strain
7%
Brown Norway Rat
7%
Contrast
7%
Magnetic Resonance Imaging
7%